Date Document
18/12/2014 Newsletter to Customers
27/11/2014 Results of AGM
27/11/2014 2014 AGM Presentation
05/11/2014 WA Innovator of the Year
03/11/2014 Appendix 4C - quarterly
30/10/2014 Final Director's Interest Notice
29/10/2014 Resignation of Director
28/10/2014 Notice of Annual General Meeting/Proxy Form
28/10/2014 Annual Report to shareholders
30/09/2014 Appendix 3B
26/09/2014 Full Year Statutory Accounts
15/09/2014 Appendix 3B
15/09/2014 Resonance Raises a further $650,000
04/09/2014 Resonance Health joins experts on liver disease Forum
28/08/2014 Preliminary Final Report Appendix 4E
27/08/2014 Finalist West Aust. Innovator of the Year
31/07/2014 Appendix 4C - quarterly
11/07/2014 Not proceeding with VueKlar acquisition
25/06/2014 Change in substantial holding
17/06/2014 Close of Entitlement Offer Notice of Shortfall
17/06/2014 Appendix 3Y Ms Liza Dunne
17/06/2014 Appendix 3Y Dr Martin Blake
06/06/2014 RHT Update
03/06/2014 RHT signs Non-Binding Heads of Agreement
02/06/2014 Clarification Statement
02/06/2014 Suspension - ASX Code RHTN (Deferred)
30/05/2014 Rights Closing Date Extension
30/05/2014 Trading Halt
29/05/2014 HepaFat-Scan gains TGA Listing and CE Mark
19/05/2014 Operational update and extension of Closing Date
02/05/2014 Rights Issue - Confirmation of dispatch of Offer Document
30/04/2014 Appendix 4C - quarterly
29/04/2014 Change of Share Registry address
23/04/2014 Notice Ineligible Shareholders
23/04/2014 Notice to Eligible Shareholders
22/04/2014 Appendix 3B - Rights Issue
22/04/2014 Cleansing Statement - Rights Issue Offer Document
17/04/2014 Cleansing Statement - Issue of Placement Shares
10/04/2014 Resonance Health Presentation
10/04/2014 Placement and entitlements offer to raise $5.1million
07/04/2014 Trading Halt
06/03/2014 CPT Code Update
28/02/2014 Half Yearly Report and Accounts
26/02/2014 Reponse to ASX Price and Volume Query
31/01/2014 Appendix 4C - quarterly
07/01/2014 Response to ASX Price and Volume Query